Zurich Precision Oncology Funding Program - Translating innovation into better cancer treatment

The Zurich Precision Oncology Funding Program supports outstanding translational cancer research projects that bridge basic science and clinical practice.

Dedicated Lighthouse Projects reflect the mission of CCCZ as a Comprehensive Cancer Center of Excellence, focusing on innovative approaches that address unmet clinical needs and rapidly translate scientific advances into patient care. By connecting interdisciplinary research, clinical oncology, and advanced technologies, the program drives the development of new diagnostic and therapeutic strategies in precision oncology.

Criteria for CCCZ Lighthouse Projects

• Scope: Innovative science with clearly visible potential for clinical translation by connecting the basic research environment with oncological patient care at CCCZ.
• Team: 4-6 investigators, all CCCZ Members, from at least two CCCZ institutions, PI must be member of faculty of medicine or science at UZH.
• Funding Period: 2027-2030
• Funding Volume: Up-to CHF 2 Mio per project
• Please refer to the guidelines and templates for detailed information.

Criteria for CCCZ Investigator Initiated Trials (IITs)

• Scope: Diagnostic tests, interventional treatments, or technologies that have a direct impact on cancer outcome. The call favors early IITs with short follow-ups and primary outcomes, which aim to establish proof of concept (including phase 1 and early phase 2a).
• Team: One principal investigator (PI) and at least one sub-investigator, PI must be a clinician and a CCCZ member, PI must be a professor or PD of the UZH faculty of medicine or affiliated with the UZH or one of the university hospitals.
• Funding Period: 2027-2030
• Funding Volume: Up-to CHF 2.6 Mio. total
• Please refer to the guidelines and templates for detailed information.